Protein neddylation and its alterations in human cancers for targeted therapy

L Zhou, W Zhang, Y Sun, L Jia - Cellular signalling, 2018 - Elsevier
Neddylation, a post-translational modification that conjugates an ubiquitin-like protein
NEDD8 to substrate proteins, is an important biochemical process that regulates protein …

E1 enzymes as therapeutic targets in cancer

SH Barghout, AD Schimmer - Pharmacological reviews, 2021 - ASPET
Post-translational modifications of cellular substrates with ubiquitin and ubiquitin-like
proteins (UBLs), including ubiquitin, SUMOs, and neural precursor cell–expressed …

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML

RT Swords, S Coutre, MB Maris… - Blood, The Journal …, 2018 - ashpublications.org
Abstract Pevonedistat (TAK-924/MLN4924) is a novel inhibitor of NEDD8-activating enzyme
(NAE) with single-agent activity in relapsed/refractory acute myeloid leukemia (AML). We …

[HTML][HTML] Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway

X Shi, L Ran, Y Liu, SH Zhong, PP Zhou… - Oncology …, 2018 - spandidos-publications.com
Cervical cancer is currently one of the major threats to women's health. The overexpression
of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP A2/B1) as the biomarker has …

Targeting protein neddylation for cancer therapy

L Zhou, L Jia - Cullin-RING Ligases and Protein Neddylation: Biology …, 2020 - Springer
Neddylation is a posttranslational modification that conjugates a ubiquitin-like protein
NEDD8 to substrate proteins. The best-characterized substrates of neddylation are the cullin …

[HTML][HTML] A promising way to overcome temozolomide resistance through inhibition of protein neddylation in glioblastoma cell lines

B Brandt, M Németh, G Berta, M Szünstein… - International Journal of …, 2023 - mdpi.com
There is no effective therapy for the lately increased incidence of glioblastoma multiforme
(GBM)—the most common primary brain tumor characterized by a high degree of …

[HTML][HTML] Targeting cullin neddylation for cancer and fibrotic diseases

ZX He, W Yang, D Zengyangzong, G Gao, Q Zhang… - Theranostics, 2023 - ncbi.nlm.nih.gov
Protein neddylation is a post-translational modification, and its best recognized substrates
are cullin family proteins, which are the core component of Cullin-RING ligases (CRLs) …

[HTML][HTML] Neddylation inhibitor MLN4924 induces G2 cell cycle arrest, DNA damage and sensitizes esophageal squamous cell carcinoma cells to cisplatin

S Lin, Z Shang, S Li, P Gao, Y Zhang… - Oncology …, 2018 - spandidos-publications.com
Inhibiting the protein neddylation pathway using the NEDD8‑activating enzyme inhibitor
MLN4924 represents an attractive anticancer strategy having been demonstrated to exhibit …

The neddylation inhibitor MLN4924 inhibits proliferation and triggers apoptosis of oral cancer cells but not for normal cells

YN Chen, YH Chan, JP Shiau… - Environmental …, 2024 - Wiley Online Library
Increased neddylation benefits the survival of several types of cancer cells. The inhibition of
neddylation has the potential to exert anticancer effects but is rarely assessed in oral cancer …

[HTML][HTML] Protein neddylation and its role in health and diseases

S Zhang, Q Yu, Z Li, Y Zhao, Y Sun - Signal Transduction and Targeted …, 2024 - nature.com
NEDD8 (Neural precursor cell expressed developmentally downregulated protein 8) is an
ubiquitin-like protein that is covalently attached to a lysine residue of a protein substrate …